{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:09:25Z","timestamp":1784740165142,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901607"],"award-info":[{"award-number":["81901607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M692495"],"award-info":[{"award-number":["2021M692495"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bbrc.2023.01.006","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:26:04Z","timestamp":1672845964000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The redirected killing of PD-L1 positive tumor cells by the expanded mucosa-associated invariant T (MAIT) cells is mediated with a bispecific antibody targeting TCR V\u03b17.2 and PD-L1"],"prefix":"10.1016","volume":"644","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-9646","authenticated-orcid":false,"given":"Rui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.01.006_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(14)71170-2","article-title":"Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study","volume":"16","author":"Topp","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib2","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/leu.2017.41","article-title":"Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL","volume":"31","author":"Duell","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2023.01.006_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095517","article-title":"Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8","volume":"9","author":"Michalk","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.01.006_bib5","article-title":"1316 A novel class of T cell-activating antibody that selectively targets the TCR b chain to promote antitumor activity through activation and expansion of a novel, polyclonal effector memory T cell subset","volume":"10","author":"Bayliffe","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.bbrc.2023.01.006_bib6","first-page":"1054","article-title":"A\u00a0single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response","volume":"1","author":"Lameris","year":"2020","journal-title":"Nat. Can. (Que.)"},{"key":"10.1016\/j.bbrc.2023.01.006_bib7","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1038\/cti.2016.51","article-title":"MAIT cells: new guardians of the liver","volume":"5","author":"Kurioka","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.bbrc.2023.01.006_bib8","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1038\/s41598-019-43578-9","article-title":"Differences in the molecular signatures of mucosal-associated invariant T cells and conventional T cells","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.01.006_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.2100856","article-title":"Engineering human MAIT cells with chimeric antigen receptors for cancer immunotherapy","volume":"209","author":"Dogan","year":"2022","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib10","article-title":"Targeting immunosuppressive tumor-associated macrophages using innate T cells for enhanced antitumor reactivity","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2023.01.006_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1084\/jem.20130958","article-title":"Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells","volume":"210","author":"Reantragoon","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2023.01.006_bib12","article-title":"IL-12 expands and differentiates human V gamma 2V delta 2 T effector cells producing antimicrobial cytokines and inhibiting intracellular mycobacterial growth","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib13","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2023.01.006_bib14","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2023.01.006_bib15","article-title":"Bispecific antibody PD-L1 x CD3 boosts the anti-tumor potency of the expanded Vgamma2Vdelta2 T cells","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib16","article-title":"Vgamma2 x PD-L1, a bispecific antibody targeting both the Vgamma2 TCR and PD-L1, improves the anti-tumor response of Vgamma2Vdelta2 T cell","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0161-5890(81)90012-2","article-title":"Partial elucidation of an anti-hapten repertoire in BALB\/c mice: comparative characterization of several monoclonal anti-fluorescyl antibodies","volume":"18","author":"Kranz","year":"1981","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib18","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.1701073","article-title":"IL-12+IL-18 cosignaling in human macrophages and lung epithelial cells activates cathelicidin and autophagy, inhibiting intracellular mycobacterial growth","volume":"200","author":"Yang","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib19","article-title":"A\u00a0CD4+CD161+T-cell subset present in unexposed humans, not Tb patients, are Fast acting cells that inhibit the growth of intracellular mycobacteria involving CD161 pathway, perforin, and IFN-gamma\/Autophagy","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib20","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1371\/journal.pbio.1000054","article-title":"Stepwise development of MAIT cells in mouse and human","volume":"7","author":"Martin","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2023.01.006_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.imbio.2012.04.003","article-title":"NKT and MAIT invariant TCRalpha sequences can be produced efficiently by VJ gene recombination","volume":"218","author":"Greenaway","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.bbrc.2023.01.006_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: a mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2023.01.006_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/abt\/tbaa011","article-title":"Development of bispecific antibodies in China: overview and prospects","volume":"3","author":"Zhang","year":"2020","journal-title":"Antibody therapeutics"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:45:07Z","timestamp":1762094707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":23,"alternative-id":["S0006291X23000128"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.006","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The redirected killing of PD-L1 positive tumor cells by the expanded mucosa-associated invariant T (MAIT) cells is mediated with a bispecific antibody targeting TCR V\u03b17.2 and PD-L1","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}